Nanobiotix S.A. (0QAV.L) LSE

22.15

-0.85(-3.70%)

Updated at February 20 04:56PM

Currency In EUR

Valuation

Market Cap141.8M
Enterprise Value142.96M
P/E Ratio-20.02
PEG Ratio-0.82
Price/Sales Ratio183.74
Price/Book Ratio-14.99
Enterprise/Revenue187.65
Enterprise/EBITDA-24.86

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-9
Operating Margin-7.65

Management Effectiveness

Return On Assets-1.14
Return On Equity0.77

Income Statement

Revenue-11.61M
Revenue/Share0.12
Gross Profit0
EBITDA-61.62M
Net Income-68.13M
Diluted EPS-1.44

Balance Sheet

Total Cash28.82M
Total Cash/Share0.61
Total Debt51.24M
Total Debt/Equity-0.74
Current Ratio0.63
Book Value Per Share-1.45

Price History

52-Week Change515.28
52-Week High22.6
52-Week Low1.62
Moving Average 50 Days6.68
Moving Average 200 Days6.55

Statistics

Average Volume8,588
Shares Outstanding48.19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A